Cardiff Lexington Signs $104M LOI to Acquire Multi-State Musculoskeletal Platform
CDIX has more than doubled off its 52-week low of $0.116.
Summary
A non-binding LOI to acquire a multi-state musculoskeletal healthcare platform for up to $104 million would dramatically expand Cardiff Lexington's operations, but the deal hinges on securing financing the company does not yet have.
Key Events · M&A and Partnerships · CDIX
-
$104M LOI for Musculoskeletal Platform
A non-binding letter of intent has been signed to acquire a multi-location musculoskeletal healthcare platform for up to $104 million in total consideration.
-
Consideration Structure
The deal includes $30M cash at closing, $10M unsecured notes due in two years, preferred equity giving sellers 35% of fully diluted equity, and up to $12M in earnout common stock.
-
Earnout Tied to EBITDA Targets
Sellers can earn $4M in stock for each of 2027, 2028, and 2029 if Target EBITDA exceeds $15M, $18M, and $22M respectively.
-
Financing Not Yet Secured
Binding financing commitments have not been obtained. With only $218K in cash as of Q2 2026, the $30M cash component is a significant hurdle.
Analysis · CDIX · Industrial Applications And Services
A micro-cap healthcare holding company with a going-concern warning and only $218K in cash as of Q2 2026 has signed a non-binding LOI to acquire a multi-location musculoskeletal healthcare platform for up to $104 million. The deal would be transformative in scale — the purchase price is roughly 11x the company's current market cap — but it is entirely contingent on financing that has not yet been secured. The consideration structure includes $30M cash at closing, $10M in notes, preferred equity giving sellers 35% of the fully diluted company, and up to $12M in earnouts tied to aggressive EBITDA targets. Given the company's distressed financial position, the ability to raise the required capital is the central risk. The LOI is non-binding, with a 45-day exclusivity period and a projected closing date of November 16, 2026.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CDIX was trading at $0.60 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $9.4M. The 52-week trading range was $0.12 to $180.00. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.